SlideShare a Scribd company logo
1 of 15
Drug
Elimination
.1
.1
.1
.1
Contents
Clinical significance
Introduction Zero order elimination
Clearance
1
3
2
4
.1 .1
5 6 Monitoring
First order elimination
Elimination:
• Once a drug enters the body, it starts getting eliminated irreversibly. This
process reduces the plasma concentration of the drug per unit time.
• When drugs dissolved in body fluids, they exist in the both ionized form
(water soluble that can’t pass BBB) and nonionized form (lipid soluble, can
pass BBB).
• Drug mainly eliminated through the kidney, and it involves three
physiological processes: glomerular filtration, proximal tubular secretion,
and distal tubular reabsorption. Glomerular filtration: Free drug flows out
of the body and into the urine-to-be as part of the glomerular filtrate.
Route of drug elimination:
1- Drug elimination in the urine
To be extensively excreted in urine, a drug or metabolite must be water soluble
and must not be bound too tightly to proteins in the bloodstream. The acidity of
urine, which is affected by diet, drugs, and kidney disorders, can affect the rate at
which the kidneys excrete some drugs.
2- Drug elimination in the bile
Some drugs pass through the liver unchanged and are excreted in the bile.
Other drugs are converted to metabolites in the liver before they are excreted
in the bile. In both scenarios, the bile then enters the digestive tract. From
there, drugs are either eliminated in feces or reabsorbed into the bloodstream
and thus recycled.
3- Others forms of elimination:
Some drugs are excreted in saliva, sweat, breast milk, and even exhaled air. Most
are excreted in small amounts. The excretion of drugs in breast milk is significant
only because the drug may affect the breastfeeding infant (drugs that
contraindicated with breastfeeding). Excretion in exhaled air is the main way that
inhaled anesthetics are eliminated.
I: Water-soluble, non-volatile, small molecular size (less than 500 daltons)
drugs are mostly eliminated through the renal route.
II: Drugs having the size greater than 500 daltons are majorly excreted in
bile.
III: Drugs having the size between 300–500 daltons are excreted both in
urine, as well as bile.
Zero order elimination
• The plasma concentration – time profile
during the elimination phase is linear
• Zero Order elimination is rather rare, mostly
occurring when the elimination system is
saturated
• Example on zero order elimination: Ethanol,
Phenytoin, Salicylates, Cisplatin, Fluoxetine and
Omeprazol.
• Zero-order kinetics is elimination of a constant quantity per time unit of the
drug quantity present in the organism
• The rate of elimination is independent of the concentration of the drug.
Zero-order elimination equation :
First-order elimination kinetics :
 Occur when a constant proportion of the drug is eliminated per unit time.
 Rate of elimination is proportional to the amount of drug in the body. The
higher the concentration, the greater the amount of drug eliminated per unit
time.
 For every half life that passes the drug concentration is halved. For
example: a drug concentration of 100 and a half life of one hour will reduce
to 50 in the first hour, 25 in the second hour and 12.5 in the 3rd hour and so
on. Elimination mechanisms are NOT saturable
• The plasma concentration – time
profile during the elimination phase
shows an exponential decrease in
the plot with linear axes and is
linear if plotted on a semi
logarithmic plot (plasma
concentration on logarithmic axis
and time on linear axis
• For example, 1% of the drug
quantity is eliminated per minute.
Many drugs are eliminated by first
order kinetics.
 The time course of the decrease of the drug concentration in the plasma can be
described by an exponential equation of the form:
Clinical Implications
 In clinical pharmacology, first order kinetics are considered as a « linear
process », because the rate of elimination is proportional to the drug
concentration. This means that the higher the drug concentration, the higher its
elimination rate. In other words, the elimination processes are not saturated and
can adapt to the needs of the body, to reduce accumulation of the drug.
 95% of the drugs in use at therapeutic concentrations are eliminated by first
order elimination kinetics.
 Because in a saturated process the elimination rate is no longer proportional
to the drug concentration but decreasing at higher concentrations, zero-order
kinetics are also called “non-linear kinetics” in clinical pharmacology.
Clearance
• Clearance is variable in zero-order kinetics because a constant amount of
the drug is eliminated per unit time, but it is constant in first-order kinetics,
because the amount of drug eliminated per unit time changes with the
concentration of drug in the blood
• Drug clearance is concerned with the rate at which the active drug is
removed from the body; and for most drugs at steady state, clearance
remains constant so that drug input equals drug output. Clearance is
defined as the rate of drug elimination divided by the plasma
Importance of clearance:
• Most drugs are given continuously. Clearance, the parameter which relates
rate of elimination to drug concentration, is important because it defines the
rate of administration required to maintain a plateau drug concentration
 The difference between clearance and elimination:
Applied Biopharmaceutics & Pharmacokinetics defines elimination as the
"irreversible removal of the drug from the body" and clearance as "volume
of fluid cleared of drug per unit time".
 The factors that affect drug clearance:
Inherent ability of the clearing organ to eliminate the drug. Any disease
process might interfere. Blood flow to the organ- which sometimes is
dependent on cardiac output. In severe cases functions of excretory organs
might be affected
Drug Elimination Monitoring:
• When taking care of patients with hepatic or renal disease or conditions
affecting those organs, we must consider the fact that drug elimination may be
affected.
• Drug doses may require reduction (and/or dosing frequency), and some drugs
may require discontinuation. If the administration of a particular drug is
absolutely necessary, careful monitoring for adverse effects is of the essence.
• In patients unaffected by liver or kidney pathology, the plasma concentration
of drugs such as vancomycin or phenytoin still needs monitoring to ensure
they remain in the therapeutic window.

More Related Content

What's hot

Drug excretion
Drug excretionDrug excretion
Drug excretion
Susie Ross
 
Excretion edited
Excretion editedExcretion edited
Excretion edited
mizan00
 
Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
Basic biopharmaceutics, pharmacokinetics, pharmacodynamicsBasic biopharmaceutics, pharmacokinetics, pharmacodynamics
Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
Diana Rangaves, PharmD, CEO
 
Drug excretion lecture 10
Drug excretion  lecture 10Drug excretion  lecture 10
Drug excretion lecture 10
homebwoi
 

What's hot (20)

Drug excretion
Drug excretionDrug excretion
Drug excretion
 
Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 
Drug excretion
Drug excretionDrug excretion
Drug excretion
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A PPharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 
Drug excretion new
Drug excretion newDrug excretion new
Drug excretion new
 
ppt on pharmacokinetics pharmacolocy
ppt on pharmacokinetics pharmacolocy ppt on pharmacokinetics pharmacolocy
ppt on pharmacokinetics pharmacolocy
 
Importance of clinical pharmacokinetic studies
Importance of clinical pharmacokinetic studiesImportance of clinical pharmacokinetic studies
Importance of clinical pharmacokinetic studies
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Basic principles of pharmacology
Basic principles of pharmacologyBasic principles of pharmacology
Basic principles of pharmacology
 
Excretion edited
Excretion editedExcretion edited
Excretion edited
 
Pk2
Pk2Pk2
Pk2
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
Basic biopharmaceutics, pharmacokinetics, pharmacodynamicsBasic biopharmaceutics, pharmacokinetics, pharmacodynamics
Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
 
Drug excretion lecture 10
Drug excretion  lecture 10Drug excretion  lecture 10
Drug excretion lecture 10
 
Basic principles in pharmacology pharmacokinetics - pharmacology
Basic principles in pharmacology pharmacokinetics - pharmacology Basic principles in pharmacology pharmacokinetics - pharmacology
Basic principles in pharmacology pharmacokinetics - pharmacology
 
Pk1 Ppt
Pk1 PptPk1 Ppt
Pk1 Ppt
 
pharmacodynamics with diagram in simple
 pharmacodynamics with diagram in simple pharmacodynamics with diagram in simple
pharmacodynamics with diagram in simple
 

Similar to kinetics.pptx

PHARMACOKINETICS all about metabolism included.pptx
PHARMACOKINETICS all about metabolism included.pptxPHARMACOKINETICS all about metabolism included.pptx
PHARMACOKINETICS all about metabolism included.pptx
mahadan07
 
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
NarayanRajaramkote
 

Similar to kinetics.pptx (20)

pharmacokinetics ppt
pharmacokinetics pptpharmacokinetics ppt
pharmacokinetics ppt
 
PHARMACOKINETICS all about metabolism included.pptx
PHARMACOKINETICS all about metabolism included.pptxPHARMACOKINETICS all about metabolism included.pptx
PHARMACOKINETICS all about metabolism included.pptx
 
Therapuetic drug monitoring
Therapuetic drug monitoringTherapuetic drug monitoring
Therapuetic drug monitoring
 
Drug-Elimination pharmacology .pptx
Drug-Elimination pharmacology      .pptxDrug-Elimination pharmacology      .pptx
Drug-Elimination pharmacology .pptx
 
PK- Basic terminologies.pptx
PK- Basic terminologies.pptxPK- Basic terminologies.pptx
PK- Basic terminologies.pptx
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
elimination kinetics of drugs.ppt
elimination kinetics of drugs.pptelimination kinetics of drugs.ppt
elimination kinetics of drugs.ppt
 
Pharmacokinetics and pharmacodynamics
Pharmacokinetics and pharmacodynamicsPharmacokinetics and pharmacodynamics
Pharmacokinetics and pharmacodynamics
 
Pharmacology part 2
Pharmacology part 2Pharmacology part 2
Pharmacology part 2
 
Basic Pharmacokintics
 Basic Pharmacokintics Basic Pharmacokintics
Basic Pharmacokintics
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Pharma Co Kinetics Filtration by Kidney
 Pharma Co Kinetics Filtration by Kidney Pharma Co Kinetics Filtration by Kidney
Pharma Co Kinetics Filtration by Kidney
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
basicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdfbasicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdf
 
Pharmacokinetics and Metabolism.pdf
Pharmacokinetics and Metabolism.pdfPharmacokinetics and Metabolism.pdf
Pharmacokinetics and Metabolism.pdf
 
ELIMIMATION OF DRUGS [YOGESH YADAV].pptx
ELIMIMATION OF DRUGS [YOGESH YADAV].pptxELIMIMATION OF DRUGS [YOGESH YADAV].pptx
ELIMIMATION OF DRUGS [YOGESH YADAV].pptx
 
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
 
Health informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptxHealth informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptx
 
PHARMACODYNAMIC & PHARMACOKINETIC.pptx
PHARMACODYNAMIC & PHARMACOKINETIC.pptxPHARMACODYNAMIC & PHARMACOKINETIC.pptx
PHARMACODYNAMIC & PHARMACOKINETIC.pptx
 
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
 

Recently uploaded

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Krashi Coaching
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
SoniaTolstoy
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 

kinetics.pptx

  • 2. .1 .1 .1 .1 Contents Clinical significance Introduction Zero order elimination Clearance 1 3 2 4 .1 .1 5 6 Monitoring First order elimination
  • 3. Elimination: • Once a drug enters the body, it starts getting eliminated irreversibly. This process reduces the plasma concentration of the drug per unit time. • When drugs dissolved in body fluids, they exist in the both ionized form (water soluble that can’t pass BBB) and nonionized form (lipid soluble, can pass BBB). • Drug mainly eliminated through the kidney, and it involves three physiological processes: glomerular filtration, proximal tubular secretion, and distal tubular reabsorption. Glomerular filtration: Free drug flows out of the body and into the urine-to-be as part of the glomerular filtrate.
  • 4. Route of drug elimination: 1- Drug elimination in the urine To be extensively excreted in urine, a drug or metabolite must be water soluble and must not be bound too tightly to proteins in the bloodstream. The acidity of urine, which is affected by diet, drugs, and kidney disorders, can affect the rate at which the kidneys excrete some drugs. 2- Drug elimination in the bile Some drugs pass through the liver unchanged and are excreted in the bile. Other drugs are converted to metabolites in the liver before they are excreted in the bile. In both scenarios, the bile then enters the digestive tract. From there, drugs are either eliminated in feces or reabsorbed into the bloodstream and thus recycled.
  • 5. 3- Others forms of elimination: Some drugs are excreted in saliva, sweat, breast milk, and even exhaled air. Most are excreted in small amounts. The excretion of drugs in breast milk is significant only because the drug may affect the breastfeeding infant (drugs that contraindicated with breastfeeding). Excretion in exhaled air is the main way that inhaled anesthetics are eliminated. I: Water-soluble, non-volatile, small molecular size (less than 500 daltons) drugs are mostly eliminated through the renal route. II: Drugs having the size greater than 500 daltons are majorly excreted in bile. III: Drugs having the size between 300–500 daltons are excreted both in urine, as well as bile.
  • 6. Zero order elimination • The plasma concentration – time profile during the elimination phase is linear • Zero Order elimination is rather rare, mostly occurring when the elimination system is saturated • Example on zero order elimination: Ethanol, Phenytoin, Salicylates, Cisplatin, Fluoxetine and Omeprazol. • Zero-order kinetics is elimination of a constant quantity per time unit of the drug quantity present in the organism • The rate of elimination is independent of the concentration of the drug.
  • 8. First-order elimination kinetics :  Occur when a constant proportion of the drug is eliminated per unit time.  Rate of elimination is proportional to the amount of drug in the body. The higher the concentration, the greater the amount of drug eliminated per unit time.  For every half life that passes the drug concentration is halved. For example: a drug concentration of 100 and a half life of one hour will reduce to 50 in the first hour, 25 in the second hour and 12.5 in the 3rd hour and so on. Elimination mechanisms are NOT saturable
  • 9. • The plasma concentration – time profile during the elimination phase shows an exponential decrease in the plot with linear axes and is linear if plotted on a semi logarithmic plot (plasma concentration on logarithmic axis and time on linear axis • For example, 1% of the drug quantity is eliminated per minute. Many drugs are eliminated by first order kinetics.
  • 10.  The time course of the decrease of the drug concentration in the plasma can be described by an exponential equation of the form:
  • 11. Clinical Implications  In clinical pharmacology, first order kinetics are considered as a « linear process », because the rate of elimination is proportional to the drug concentration. This means that the higher the drug concentration, the higher its elimination rate. In other words, the elimination processes are not saturated and can adapt to the needs of the body, to reduce accumulation of the drug.  95% of the drugs in use at therapeutic concentrations are eliminated by first order elimination kinetics.  Because in a saturated process the elimination rate is no longer proportional to the drug concentration but decreasing at higher concentrations, zero-order kinetics are also called “non-linear kinetics” in clinical pharmacology.
  • 12. Clearance • Clearance is variable in zero-order kinetics because a constant amount of the drug is eliminated per unit time, but it is constant in first-order kinetics, because the amount of drug eliminated per unit time changes with the concentration of drug in the blood • Drug clearance is concerned with the rate at which the active drug is removed from the body; and for most drugs at steady state, clearance remains constant so that drug input equals drug output. Clearance is defined as the rate of drug elimination divided by the plasma
  • 13. Importance of clearance: • Most drugs are given continuously. Clearance, the parameter which relates rate of elimination to drug concentration, is important because it defines the rate of administration required to maintain a plateau drug concentration
  • 14.  The difference between clearance and elimination: Applied Biopharmaceutics & Pharmacokinetics defines elimination as the "irreversible removal of the drug from the body" and clearance as "volume of fluid cleared of drug per unit time".  The factors that affect drug clearance: Inherent ability of the clearing organ to eliminate the drug. Any disease process might interfere. Blood flow to the organ- which sometimes is dependent on cardiac output. In severe cases functions of excretory organs might be affected
  • 15. Drug Elimination Monitoring: • When taking care of patients with hepatic or renal disease or conditions affecting those organs, we must consider the fact that drug elimination may be affected. • Drug doses may require reduction (and/or dosing frequency), and some drugs may require discontinuation. If the administration of a particular drug is absolutely necessary, careful monitoring for adverse effects is of the essence. • In patients unaffected by liver or kidney pathology, the plasma concentration of drugs such as vancomycin or phenytoin still needs monitoring to ensure they remain in the therapeutic window.